| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 3.17M | — |
| Operating expense | — | — |
| Net income | -24.47M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VT6.F returned +5.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -13.7% |
| 1 year | +5.7% |
| 5 years | +4.8% |
| 10 years | -73.9% |
| All-time high | €25.46 (Nov 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in VT6.F would be worth today ›No. Voyager Therapeutics, Inc. has not paid a dividend in the past 12 months.
Voyager Therapeutics, Inc. is part of the Healthcare sector.
Voyager Therapeutics, Inc. has a market cap of 173.52M EUR, based on the latest quote.
